What's new

New Delhi Vs Washington : India to block US Trade Probe - ready for fight at WTO

Indo-guy

SENIOR MEMBER
Joined
Aug 14, 2013
Messages
4,820
Reaction score
2
Country
India
Location
Singapore
India to block US trade probes, ready for fight at WTO - The Times of India


NEW DELHI: India has decided to block investigations by the United States into its trade policies and patent laws, and prepare for a battle at the World Trade Organization (WTO), a move that could escalate already-strained tension between the two countries.

New Delhi is furious about a threat of trade sanctions made by the US trade representative's (USTR) office over its protection of intellectual property rights (IPR), preference for domestic producers and non-trade barriers.

Ahead of a general election, Prime Minister Manmohan Singh's government does not want to be seen as bowing to US pressure, amid lingering tension over the recent arrest and strip search of a female diplomat in New York suspected of visa fraud


On Wednesday, the National Association of Manufacturers (NAM) — which represents about 50 US business groups — asked the USTR to designate India a "priority foreign country" in its 2014 report.

"This designation appropriately would rank India among the very worst violators of intellectual property rights and establish a process leading to concrete solutions," NAM said in a letter to US trade representative Michael Froman.

The USTR is holding public hearings for its annual report due in April. The report will provide details on nations denying protection of IP rights or fair market access to US firms.

India is widely perceived in Washington as a serial trade offender, with US firms unhappy about imports of everything from shrimp to steel pipes they say threaten jobs, as well as a lack of fair access to the Indian market for its goods.

WTO cases

This month, Washington said it was filing its second case at the WTO over domestic content requirements in India's solar programme, which aims to ease energy shortages in Asia's third-largest economy.

There are 14 past or current WTO cases between India and the United States, whose bilateral trade in goods measured $63.7 billion last year, not including the latest case.

India has since hardened its stance, instructing officials not to entertain any request from the United States international trade commission (USITC) — a quasi-judicial federal agency — to examine its trade practices.

India's trade ministry has also "advised" US deputy trade representative Wendy Cutler to put off a visit to India that had been scheduled for late March due to the parliamentary election due in April or May, a senior official told Reuters.

The official said India had asked for alternative dates for the visit, possibly after the elections, adding that the decision was not linked with the trade tension.

Worst offenders

The USTR listed in a February 12 report markets in Delhi, Mumbai and Hyderabad as being among the worst offenders globally for the sale of pirated software and counterfeit goods.

A visit by the USITC delegation to meet officials from the Indian commerce, industry, health, telecom and finance ministries has also been put on hold.

A USITC spokeswoman confirmed the delay, saying they were looking for "other windows" for a visit, but declined to comment on the reasons for the delay.

Newly appointed trade secretary Rajeev Kher, who pushed India's stand on food security issues at a WTO meeting in Bali, as chief WTO negotiator, has told his officials to tackle bilateral trade disputes preferably through multi-lateral forums.

India has also urged President Barack Obama's administration not to fall prey to special interest groups and consider trade issues in the context of the wider economic and strategic relationship between the two countries.

Officials say any move towards putting India on a priority foreign countries list would hurt bilateral relations.

"There are clear stresses in the India-US trade, economic relations," said another government official who, like others who spoke to Reuters, declined to be identified due to the sensitivity of the matter.

"If it is a strategic relationship, they should be looking at the larger picture."
 
.
Good Decision...by the way,they're going to lose just like Swiss giant Novatis...also,the main reason is this....

American pharma companies had objected India's move to issue a compulsory license (CL) in March, 2012 to Hyderabad- based Natco PharmaBSE -0.23 % to manufacture and sell cancer-treatment drug 'Nexavar' at a price over 30 times lower than charged by patent-holder BayerBSE -1.71 % Corporation.

The USITC has raised this issue besides the rejection of patent to Bristol-Myers Squibb's Sprycel and Novartis' Gleevec. It has stated that Indian IPR laws are not Trade Related Aspects of Intellectual Property Rights (TRIPS) compliant under the WTO.


India may take US to WTO if included in priority country list - The Economic Times
 
.
New Delhi is furious about a threat of trade sanctions made by the US trade representative's (USTR) office over its protection of intellectual property rights (IPR), preference for domestic producers and non-trade barriers.

Ahead of a general election, Prime Minister Manmohan Singh's government does not want to be seen as bowing to US pressure, amid lingering tension over the recent arrest and strip search of a female diplomat in New York suspected of visa fraud.

The American Empire strikes again.

Good luck India, teach the imperialists a lesson by winning the case.
 
.
The American Empire strikes again.

Good luck India, teach the imperialists a lesson by winning the case.

India is expected to have a high number of cancer patients as a percentage that would rely on said drugs.

These restrictive moves are meant to pander to the global pharma giants so that they can charge exorbitant rates for drugs that Indian pharmas can produce for just a tiny fraction of the cost.

making exorbitant profits is more important to these bastards than human lives, especially when it comes to 3rd world citizen's lives( who obviously cannot afford it).

No way India is bowing down to these money lynching bastards come what may.
 
.
These restrictive moves are meant to pander to the global pharma giants so that they can charge exorbitant rates for drugs that Indian pharmas can produce for just a tiny fraction of the cost.

making exorbitant profits is more important to these bastards than human lives, especially when it comes to 3rd world citizen's lives( who obviously cannot afford it).

So basically, they are saying that it is better to make American billionaires even richer, rather than to give medicine to your own people who need it to live.
 
.
So basically, they are saying that it is better to make American billionaires even richer, rather than to give medicine to your own people who need it to live.

They may say whatever, but once it comes to our own people - the world be damned.

Another reason they are pissed is, we supply the same drugs at a tiny fraction of the price to poverty ravaged African countries.
 
. .
Good. Excellent. I support that 100%.

I will shed no tears when some American pharmaceutical billionaire isn't able to buy a second private jet.

Who gives a fack if they can afford a second jet or not - let them fleece their own health programs dry.
 
. . .
But at a fraction of American health and safety standard.

got whipped in other thread,but yet come here to troll???

anyway,welcome...

Any Drugs that enters into USA market has to qualify for its standard..any drugs that isn't upto that standard never going to market.and its not only in USA,but everywhere..but even then,$h!t happens..like Chinese Drug that killed several people in USA(not to mention about numbers in their own country).

but even then,they've to prove that its "Counterfeit" or "Low Standard"..until proven,nobody can stop its selling.lets prove them first(its hard as they already certified that this drug is alright).
 
.
got whipped in other thread,but yet come here to troll???

anyway,welcome...

Any Drugs that enters into USA market has to qualify for its standard..any drugs that isn't upto that standard never going to market.and its not only in USA,but everywhere..but even then,$h!t happens..like Chinese Drug that killed several people in USA(not to mention about numbers in their own country).

but even then,they've to prove that its "Counterfeit" or "Low Standard"..until proven,nobody can stop its selling.lets prove them first(its hard as they already certified that this drug is alright).

Not trolling, there was already a thread about substantard Indian pharma products. You can do a search.

Here:
Ranbaxy USA pleads guilty to selling substandard drugs - UPI.com

Four Indian drug companies blacklisted | Daily News Online : Sri Lanka's National News

Bad medicine: Is India’s pharma sector making the world sick? | iPolitics

Urine spills stain Wockhardt’s image during FDA inspection - Livemint

This is not about Chinese drugs and i don't care if Chinese drugs kill people because indian and american pharma over the counter drug skill 50,000 people every year in the USA.
 
Last edited:
.
Not trolling, there was already a thread about substantard Indian pharma products. You can do a search. This is not about Chinese drugs and i don't care if Chinese drugs kill people because indian and american pharma over the counter drug skill 50,000 people every year in the USA.

yup..I heard that too...but can they prove this???answer is no...read this...

When half a million Americans died and nobody noticed | News | The Week UK

and its not about "Fake Drug"..its about IP rights.
 
.
Good. Excellent. I support that 100%.

I will shed no tears when some American pharmaceutical billionaire isn't able to buy a second private jet.
Cheap generic drugs from India turned the tide against HIV and this court case means this can continue

When I started working in sub-Saharan Africa in the mid-1990s, HIV/Aids was cutting a seemingly unstoppable swath through families, communities, workplaces. At the time, HIV medicines cost more than $10,000 per person per year. The world seemed to accept the unacceptable fact that life-saving drugs were priced out of reach for millions of people in poor countries. The doctors I worked with were not prepared to accept this inequality, and together with brave patients and activists around the globe, we sought to change it.

The availability of affordable, quality generic medicines made in India was a critical factor in helping turn the tide in the fight against HIV/Aids. Fierce competition among producers in India, where there were no patents on medicines until 2005, caused the price of HIV medicines to plummet by 99 per cent to roughly $100 today for a year’s treatment.

For my organisation Médecins Sans Frontières, more than 80 per cent of the HIV medicines we use across the globe are manufactured in India. And we are not alone – big international aid donors also get a similar proportion of HIV drugs in India. It is known as the “pharmacy of the developing world”.

Cheap generic drugs from India turned the tide against HIV and this court case means this can continue - Comment - Voices - The Independent

Watch this video and the full documentary if you can lay your hands on it.

 
. .

Latest posts

Back
Top Bottom